Forum 2026 is a premier invite-only event uniting top pharma and healthcare supply chain leaders. This exclusive platform explores cutting-edge innovations in AI, IoT, blockchain, and cold chain logistics, while fostering valuable networking and...
and biotechnology. Scheduled to take place on October 12–13, 2026, in Singapore, the conference serves as a global platform to exchange knowledge, discuss emerging trends, and foster collaborations that accelerate drug discovery and therapeutic...
Day: Celebrate breakthroughs and emerging players shaping the next generation of therapies. And More to Come: Fresh formats, dynamic networking experiences, and unique ways to connect across disciplines. Be part of the next chapter in life...
technologies and practical solutions. In this 8th edition as we explore the novel technologies and developments reforming pharmaceutical industry, we also dive deep into the implementation and advances in machine learning, deep learning, artificial...
2nd Annual MaxPotent Pharma Summit – a leading international platform bringing together senior executives, regulatory authorities, technology providers, and pharmaceutical innovators dedicated to advancing the future of Highly Potent Active...
for Open Innovation Bridging Human, Environment and Materials. The aim objective of ICCBS 2026 is to provide a platform for researchers, engineers, academicians as well as industrial professionals from all over the world to present their research...
under the theme “Nanotechnology for Tomorrow: Precision, Progress, and Possibilities”, is designed to provide a unique platform for interdisciplinary collaboration, where researchers, innovators, and industry leaders can explore the most recent...
relevant, addressing critical topics and fostering meaningful connections. This conference promises to be a pivotal platform for advancing knowledge and expanding professional networks.
developing innovative technologies and products based on its proprietary recombinant human collagen (rhCollagen) platform, today announced the launch of BioFlex, a ready-to-print rhCollagen-based kit designed for Digital Light Processing (DLP) 3D...
enable disease researchers to move beyond canonical protein lists toward biologically or pathologically functional proteoforms and PTM-resolved peptide variants. New releases in Bruker ProteoScape™, OmniScape™, and GlycoScape™ software now support...
The most recent data released from the Co-PSMA study clearly establishes that 64Cu-SAR-bisPSMA considerably outperforms its competitors in detecting prostate cancer recurrence and sheds light on the importance of the improved lesion detection,...
PureTech Health plc a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, announced that the U.S. Food and Drug Administration (FDA) and European Commission have granted Orphan Drug...
& Decision Modelling, who will lead evidence synthesis, advanced statistical analysis, and economic modelling that inform market access and Health Technology Appraisal (HTA) decision making within the Access Consulting and Health Economics and...
studies. This is a significant finding for patients, as it offers a potentially reliable strategy for providers and transformative opportunity for patients to manage their IBD journey even when treatment is interrupted.” “In clinical practice,...
factory for drug discovery programs, integrating a chemical compound repository with a high-throughput screening (HTS) platform. Its mission is to act as a bridge between academic research and pharmaceutical development, with a particular focus on...
in vitro and in vivo models into clinical studies. Their 30 years of foundational research now provide a robust platform for launching a new generation of anticancer treatments based on isotopic modulation. HYD LLC is actively seeking investment...
life-changing therapies wherever patients are treated. This clearance aligns with our strategy to extend the Freedom platform to more drug therapies, more settings, and more patients.” KORU Medical’s Freedom Infusion System enables, simplifies, and...
M.D. highlight TONMYA'S role as a centrally-acting, differentiated non-opioid treatment. TONMYA'S unique sublingual formulation is designed for bedtime administration and to bypass first-pass metabolism, resulting in a pharmacokinetic profile that...
the European Association for the Study of the Liver (EASL) consistently identify HDV–HBV co-infection as the most severe form of chronic viral hepatitis due to rapid progression towards liver cirrhosis, hepatocellular carcinoma and liver-related...
pharma leaders Who Should Attend: Pharma marketing, digital, commercial, brand, patient engagement, innovation, and transformation leaders seeking practical strategies to stay ahead in a rapidly evolving landscape. Why Attend: Gain real-world...
